pharma · Idiopathic Pulmonary Fibrosis · Idiopathic pulmonary fibrosis (IPF) · PLRX
PLIANT THERAPEUTICS
PLIANT THERAPEUTICS, INC.
PLIANT THERAPEUTICS clinical programs — 6 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- South San Francisco, USA
- Founded
- 2015
- Employees
- 122
- Programs
- 6
- Drugs
- 3
- Patents
- 13
PLIANT THERAPEUTICS projects
6 ClinicalTrials.gov programs sponsored by PLIANT THERAPEUTICS.
PLIANT THERAPEUTICS has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Bexotegrast, Placebo matching PLN-74809
PLIANT THERAPEUTICS, INC.
Idiopathic pulmonary fibrosis (IPF)
1 trial -
PLN-74809
PLIANT THERAPEUTICS, INC.
Acute Respiratory Distress Syndrome
1 trial -
PLN-74809
PLIANT THERAPEUTICS, INC.
Idiopathic Pulmonary Fibrosis
4 trials -
PLN-74809
PLIANT THERAPEUTICS, INC.
Primary Sclerosing Cholangitis
1 trial -
PLN-101095
PLIANT THERAPEUTICS, INC.
Advanced or Metastatic Solid Tumor
1 trial -
[18F]FP-R01-MG-F2
PLIANT THERAPEUTICS, INC.
Idiopathic Pulmonary Fibrosis
1 trial
Frequently asked questions
How many clinical projects does PLIANT THERAPEUTICS have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.